Hence, understanding the regulatory mechanisms for integrins’ expression, the risk-benefits associated with anti-integrin blockade, and the contribution of each integrin for the migration and retention of a healthy CD8+:CD4+T cell ratio in the mucosa will help advancing towards better therapeutic and preventive strategies against infections such as HIV. This evidence concerns the gene CD8A and infection.